1 Result(s)

Article

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

This study was designed to compare cisplatin/docetaxel with oxaliplatin/docetaxel in patients with advanced and metastatic non-small lung cancer as a first-line treatment.

A Atmaca, S-E Al-Batran, D Werner, C Pauligk, T Güner… in British Journal of Cancer (2013)